Lymphatica Medtech develops medical devices for lymphatic disease treatment. The first product, LymphoDRAIN, is the worldwide first active lymphatic bypass for the treatment of chronic lymphedema, a disabling disease affecting millions of people worldwide.
Lymphatica developed its implantable drainage technology as a results of years of research at the Lausanne Federal Institute of Technology (EPFL) and of the Lausanne University Hospital (CHUV).

Press releases

HTGF Investment Lymphatica

Lymphatica Medtech raises seven-digit Series A round LYMPHATICA Medtech, a vascular medical device development start-up, closes a seven-digit financing round to advance clinical validation aiming at revolutionizing the treatment of chronic lymphoedema. The investment…

Info & Contact


EPFL Innovation Park – Building E
1015 Lausanne (Switzerland)

In portfolio

09. Nov 2020